TP53 and central nervous system cancer: Although previous studies have reported a lower TP53 mutations frequency in high grade glioma patients under the age of 3 years than older children, suggesting that there may be two distinct pathways involved in the tumorigenesis [7, 8], TP53 mutations have been rarely reported in PA [9].